Vimarsana
Biggest News Aggregation in the World

Page 37 - Accessed March News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Accessed March. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Accessed March Today - Breaking & Trending Today

Nerivio Device Cleared for Migraine Prevention - Vimarsana News

Nerivio Device Cleared for Migraine Prevention

The FDA has cleared Nerivio for the preventative treatment of migraine with or without aura in patients 12 years of age and older.

Source: empr.com
Emerphed Now Available in Ready-to-Use Prefilled Syringes - Vimarsana News

Emerphed Now Available in Ready-to-Use Prefilled Syringes

The FDA has approved new single-dose prefilled syringes for Emerphed (ephedrine sulfate) for clinically important hypotension.

Source: empr.com
Nerivio Device Cleared for Migraine Prevention - Vimarsana News

Nerivio Device Cleared for Migraine Prevention

The FDA has cleared Nerivio for the preventative treatment of migraine with or without aura in patients 12 years of age and older.

Source: empr.com
January 2023 CDMO Opportunities And Threats Report - Vimarsana News

January 2023 CDMO Opportunities And Threats Report

Each month, Outsourced Pharma works in conjunction with PharmSource, part of GlobalData, to present its “Contract Manufacturing: Opportunities...

NeuroDerm Ltd.: NeuroDerm Announces Highly Positive Results from the Pivotal Phase III BouNDless Trial Evaluating ND0612 in Parkinson's Disease Patients with Motor Fluctuations - Vimarsana News

NeuroDerm Ltd.: NeuroDerm Announces Highly Positive Results from the Pivotal Phase III BouNDless Trial Evaluating ND0612 in Parkinson's Disease Patients with Motor Fluctuations

ND0612, a continuous 24 hours/day subcutaneous (SC) infusion?of liquid levodopa/carbidopa (LD/CD), showed superior efficacy compared to oral LD/CD for the primary endpoint ("ON" time without